SOURCE-LINKED INTELLIGENCE

AI-driven IP Intelligence Engine for Drug Discovery

CORDIS · observation · Publication date unknown

gine enabling users to search, analyze and extract complex knowledge on chemical-biological interactions in patents. Our proprietary State-of-the-art technology combines Natural Language Processing + Machine Learning + Full linguistic data analysis + Chemical structure processing and Image Recognition, delivering novel ways by integrating two languages: chemical structure and words, into a single semantic meaning. The target audience for this solution is small and medium-sized life science companies, which currently have limitations in accessing expensive biochemistry databases. We are aiming to disrupt the life science industry by delivering a low-cost solution to enable small & medium market players to create value by protecting their IP. AI, Drug Discovery, Machine learning, Intelectual Property, Pharma

Read original source ↗ Open in workspace

recordType

award

status

CLOSED

region

EU

value

75000

unit

EUR